{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T08:09:02Z","timestamp":1771920542251,"version":"3.50.1"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003995","name":"Anhui Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["2508085QH323"],"award-info":[{"award-number":["2508085QH323"]}],"id":[{"id":"10.13039\/501100003995","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002947","name":"Anhui Medical University","doi-asserted-by":"publisher","award":["0301045203"],"award-info":[{"award-number":["0301045203"]}],"id":[{"id":"10.13039\/501100002947","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.ejmech.2026.118570","type":"journal-article","created":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T07:22:35Z","timestamp":1768807355000},"page":"118570","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Design and anti-inflammatory activity evaluation of tryptophan analogs as novel dipeptidyl peptidase I inhibitors"],"prefix":"10.1016","volume":"306","author":[{"given":"Daxing","family":"Shi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xianan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingyuan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chenxiao","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiansong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feilong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8558-4743","authenticated-orcid":false,"given":"Xing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2026.118570_bib1","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/nri3399","article-title":"Neutrophil recruitment and function in health and inflammation","volume":"13","author":"Kolaczkowska","year":"2013","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ejmech.2026.118570_bib2","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/nri1785","article-title":"Neutrophils and immunity: challenges and opportunities","volume":"6","author":"Nathan","year":"2006","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ejmech.2026.118570_bib3","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/nri.2016.49","article-title":"Neutrophil migration in infection and wound repair: going forward in reverse","volume":"16","author":"de Oliveira","year":"2016","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ejmech.2026.118570_bib4","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.pharmthera.2018.05.011","article-title":"Therapeutic targeting of cathepsin C: from pathophysiology to treatment","volume":"190","author":"Korkmaz","year":"2018","journal-title":"Pharmacology & Therapeutics"},{"key":"10.1016\/j.ejmech.2026.118570_bib5","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1124\/pr.110.002733","article-title":"Neutrophil elastase, proteinase 3, and cathepsin G as therapeutic targets in human diseases","volume":"62","author":"Korkmaz","year":"2010","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ejmech.2026.118570_bib6","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1124\/pr.115.012104","article-title":"Inhibitors and antibody fragments as potential anti-inflammatory therapeutics targeting neutrophil proteinase 3 in human disease","volume":"68","author":"Korkmaz","year":"2016","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ejmech.2026.118570_bib7","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-025-07857-w","article-title":"Exploring the involvement of serine proteases in neutrophil extracellular traps: a review of mechanisms and implications","volume":"16","author":"Korba-Miko\u0142ajczyk","year":"2025","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ejmech.2026.118570_bib8","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/nri.2017.105","article-title":"Neutrophil extracellular traps in immunity and disease","volume":"18","author":"Papayannopoulos","year":"2017","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ejmech.2026.118570_bib9","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0179-2024","article-title":"Neutrophilic inflammation in bronchiectasis","volume":"34","author":"Chalmers","year":"2025","journal-title":"Eur. Respir. Rev."},{"key":"10.1016\/j.ejmech.2026.118570_bib10","article-title":"Versatile roles for neutrophil proteinase 3 in hematopoiesis and inflammation","volume":"73","author":"Zhu","year":"2024","journal-title":"Immunol. Res."},{"key":"10.1016\/j.ejmech.2026.118570_bib11","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01050-2024","article-title":"Targeting neutrophil serine proteases in bronchiectasis","volume":"65","author":"Chalmers","year":"2025","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.ejmech.2026.118570_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106881","article-title":"Human breast milk oligosaccharides attenuate necrotizing enterocolitis in rats by suppressing mast cell accumulation, DPPI activity and TLR4 expression in ileum tissue, and regulating mitochondrial damage of Caco-2 cells","volume":"88","author":"He-Yang","year":"2020","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.ejmech.2026.118570_bib13","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.ccell.2020.12.012","article-title":"Cathepsin C promotes breast cancer lung metastasis by modulating neutrophil infiltration and neutrophil extracellular trap formation","volume":"39","author":"Xiao","year":"2021","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ejmech.2026.118570_bib14","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1074\/jbc.RA118.004376","article-title":"Deficiency of cathepsin C ameliorates severity of acute pancreatitis by reduction of neutrophil elastase activation and cleavage of E-cadherin","volume":"294","author":"John","year":"2019","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2026.118570_bib15","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1513\/pats.200906-039DS","article-title":"New and controversial therapies for chronic obstructive pulmonary disease","volume":"6","author":"Bourbeau","year":"2009","journal-title":"Proc. Am. Thorac. Soc."},{"key":"10.1016\/j.ejmech.2026.118570_bib16","doi-asserted-by":"crossref","first-page":"13258","DOI":"10.1021\/acs.jmedchem.0c00776","article-title":"Lung protection by cathepsin C inhibition: a new hope for COVID-19 and ARDS?","volume":"63","author":"Korkmaz","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118570_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113818","article-title":"Cathepsin C inhibitors as anti-inflammatory drug discovery: challenges and opportunities","volume":"225","author":"Shen","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118570_bib18","doi-asserted-by":"crossref","DOI":"10.1186\/s12967-024-05589-7","article-title":"Cathepsin C in health and disease: from structural insights to therapeutic prospects","volume":"22","author":"Chitsamankhun","year":"2024","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.ejmech.2026.118570_bib19","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1172\/JCI0213462","article-title":"Dipeptidyl peptidase I activates neutrophil-derived serine proteases and regulates the development of acute experimental arthritis","volume":"109","author":"Adkison","year":"2002","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.ejmech.2026.118570_bib20","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1124\/mol.108.045682","article-title":"In vivo inhibition of serine protease processing requires a high fractional inhibition of cathepsin C","volume":"73","author":"M\u00e9thot","year":"2008","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejmech.2026.118570_bib21","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.bcp.2017.02.009","article-title":"Prolonged pharmacological inhibition of cathepsin C results in elimination of neutrophil serine proteases","volume":"131","author":"Guarino","year":"2017","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2026.118570_bib22","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1396710","article-title":"Pharmacologic inhibition of dipeptidyl peptidase 1 (cathepsin C) does not block in vitro granzyme-mediated target cell killing by CD8 T or NK cells","volume":"15","author":"Sutton","year":"2024","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejmech.2026.118570_bib23","doi-asserted-by":"crossref","DOI":"10.1515\/BC.2003.169","article-title":"Mast cell cathepsins C and S control levels of carboxypeptidase A and the chymase, mouse mast cell protease 5","volume":"384","author":"Henningsson","year":"2003","journal-title":"Biol. Chem."},{"key":"10.1016\/j.ejmech.2026.118570_bib24","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.4049\/jimmunol.1001806","article-title":"Processing of human protryptase in mast cells involves cathepsins L, B, and C","volume":"187","author":"Le","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejmech.2026.118570_bib25","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1111\/bcp.13398","article-title":"Epithelial desquamation observed in a phase I study of an oral cathepsin C inhibitor (GSK-2793660)","volume":"83","author":"Miller","year":"2017","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejmech.2026.118570_bib26","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/S2213-2600(22)00261-2","article-title":"Dipeptidyl peptidase-1 inhibition in patients hospitalised with COVID-19: a multicentre, double-blind, randomised, parallel-group, placebo-controlled trial","volume":"10","author":"Keir","year":"2022","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.ejmech.2026.118570_bib27","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01551-2024","article-title":"Cathepsin C (dipeptidyl peptidase 1) inhibition in adults with bronchiectasis: AIRLEAF, a phase II randomised, double-blind, placebo-controlled, dose-finding study","volume":"65","author":"Chalmers","year":"2025","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.ejmech.2026.118570_bib28","doi-asserted-by":"crossref","first-page":"11857","DOI":"10.1021\/acs.jmedchem.1c00104","article-title":"Discovery and in vivo anti-inflammatory activity evaluation of a novel non-peptidyl non-covalent cathepsin C inhibitor","volume":"64","author":"Chen","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118570_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114368","article-title":"Non-peptidyl non-covalent cathepsin C inhibitoEEr bearing a unique thiophene-substituted pyridine: design, structure-activity relationship and anti-inflammatory activity in vivo","volume":"236","author":"Chen","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118570_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116914","article-title":"Identification of novel indolinone derivatives as CTSC inhibitors to treat inflammatory bowel disease by modulating inflammatory factors","volume":"280","author":"Chen","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118570_bib31","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-024-50747-6","article-title":"Cathepsin C inhibition reduces neutrophil serine protease activity and improves activated neutrophil-mediated disorders","volume":"15","author":"Nishibata","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2026.118570_bib32","doi-asserted-by":"crossref","first-page":"12100","DOI":"10.1021\/acs.jmedchem.5c00954","article-title":"Discovery of novel potent molecule for treating cisplatin-induced acute kidney injury driven by phenotypic screening","volume":"68","author":"Lou","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118570_bib33","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0003-9861(56)90172-2","article-title":"Studies on beef spleen cathepsin C1","volume":"65","author":"Fruton","year":"1956","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.ejmech.2026.118570_bib34","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1146\/annurev-pharmtox-010715-103715","article-title":"The cellular thermal shift assay: a novel biophysical assay for in situ drug target engagement and mechanistic biomarker studies","volume":"56","author":"Martinez Molina","year":"2016","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.ejmech.2026.118570_bib35","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1681\/ASN.2010080892","article-title":"Neutrophil serine proteases promote IL-1\u03b2 generation and injury in necrotizing crescentic glomerulonephritis","volume":"23","author":"Schreiber","year":"2012","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.ejmech.2026.118570_bib36","doi-asserted-by":"crossref","DOI":"10.1186\/s12974-019-1398-3","article-title":"Cathepsin C promotes microglia M1 polarization and aggravates neuroinflammation via activation of Ca2+-dependent PKC\/p38MAPK\/NF-\u03baB pathway","volume":"16","author":"Liu","year":"2019","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.ejmech.2026.118570_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2021.105107","article-title":"Cathepsin C aggravates neuroinflammation via promoting production of CCL2 and CXCL2 in glial cells and neurons in a cryogenic brain lesion","volume":"148","author":"Zhao","year":"2021","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.ejmech.2026.118570_bib38","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.abb.2004.04.011","article-title":"Design and evaluation of inhibitors for dipeptidyl peptidase I (Cathepsin C)","volume":"427","author":"Kam","year":"2004","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.ejmech.2026.118570_bib39","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1021\/ml100212k","article-title":"Discovery of novel cyanamide-based inhibitors of cathepsin C","volume":"2","author":"Lain\u00e9","year":"2010","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2026.118570_bib40","doi-asserted-by":"crossref","first-page":"708","DOI":"10.2174\/156802610791113469","article-title":"Therapeutic utility and medicinal chemistry of cathepsin C inhibitors","volume":"10","author":"Guay","year":"2010","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118570_bib41","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1517\/13543771003657172","article-title":"Inhibitors of cathepsin C (dipeptidyl peptidase I)","volume":"20","author":"Laine","year":"2010","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.ejmech.2026.118570_bib42","doi-asserted-by":"crossref","first-page":"434","DOI":"10.3762\/bjoc.19.33","article-title":"Dipeptide analogues of fluorinated aminophosphonic acid sodium salts as moderate competitive inhibitors of cathepsin C","volume":"19","author":"W\u0105troba","year":"2023","journal-title":"Beilstein J. Org. Chem."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426000152?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426000152?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T05:34:31Z","timestamp":1771911271000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523426000152"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":42,"alternative-id":["S0223523426000152"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.118570","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design and anti-inflammatory activity evaluation of tryptophan analogs as novel dipeptidyl peptidase I inhibitors","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.118570","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118570"}}